Tenaya Therapeutics, Inc. (TNYA) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts TNYA Hot Sheet
Join SI Premium – FREE
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q1 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $200 thousand.
For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- Cohen & Steers AUM rises to $100.1B in June 2026
- ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
